Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis

Despite high mortality of alcohol-associated hepatitis, there has been limited advancement in treatment strategies. Defeat Alcoholic Steatohepatitis (DASH) is a multicenter, randomized, double-blind controlled trial whose primary objective was to evaluate the safety and efficacy of a novel combination of 3 drugs targeting different perturbations in AH.

Source: Contemporary Clinical Trials - July 29, 2020 Category: Radiology Authors: Srinivasan Dasarathy, Mack C. Mitchell, Bruce Barton, Craig J. McClain, Gyongyi Szabo, Laura E. Nagy, Svetlana Radaeva, Arthur J. McCullough Source Type: research